Following the functional analyses indicating an effect of SEC62 and SOX2 expression on cell migration, we correlated the results of the immunohistochemical SEC62 and SOX2 expression analyses in the lymph node metastases of the included HNSCC and CUP patients with their survival data (Figure 6). Here, SEC62 is linked to head and neck squamous cell carcinoma.